Professor of Medicine, University of Pennsylvania
Oncology
Dr. Selina Luger, MD
|
|
Give Review
Selina Luger, MD is an expert in the field of Oncology. She over the years received 4 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Selina Luger, MD is a published doctor. She has 27 publications published. The most current publication "Allogeneic transplant for FLT3-ITD+ AML: room for improvement." Selina Luger accepts Medicare.
Publications
- Allogeneic transplant for FLT3-ITD+ AML: room for improvement.
- A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic Leukemia in old...
- Revisiting maintenance therapy in Acute myeloid leukemia with novel agents.
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Infusion of CD3/CD28 co-stimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance enGraftment.
- Approach to patients with primary refractory Acute myeloid leukemia.
- Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with Acute myeloid leukemia: A report from the Children's Onc...
- Combined B12 and folate deficiency presenting as an aggressive hematologic malignancy.
- DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia.
- A genome-wide association study of susceptibility to Acute lymphoblastic leukemia in adolescents and young adults.
- Acute cholecystitis is a common complication following allogeneic SCT and is associated with use of total parenteral nutrition.
- Early donor chimerism levels predict relapse and survival after allogeneic stem-cell transplantation with reduced intensity conditioning.
- Younger adults with Acute myeloid leukemia in remission for â¥3 years have a high likelihood of cure: The ECOG experience in over 1200 patients.
- Will FLT3 inhibitors fulfill their promise in Acute meyloid leukemia?
- Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia Vera or essential thrombocythaemia with JAK2-V617F mutation.
- Phase I study of UCN-01 and perifosine in patients with relapsed and refractory Acute leukemias and high-risk myelodysplastic syndrome.
- Receipt of maintenance therapy is most predictive of survival in older Acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in Acute myeloid leukemia.
- A Pilot Study of Prophylactic Ex Vivo Co-Stimulated Donor Leukocyte Infusions After Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation.
- Acute myeloid leukemia with translocation t(8;16) presents with features which mimic Acute promyelocytic leukemia and is associated with poor prognosis.
- Oral sapacitabine for the treatment of Acute myeloid leukaemia in elderly patients: a randomised phase 2 study.
- Blockade of lymphocyte chemotaxis in visceral Graft-versus-host disease.
- Prognostic relevance of integrated genetic profiling in Acute myeloid leukemia.
- Single-cell Pharmacodynamic Monitoring of S6 Ribosomal Protein Phosphorylation in AML Blasts During a Clinical Trial Combining the mTOR Inhibitor Sirolimus and Intensi...
- Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.
- Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared wit...
Schools
McGill University Faculty Of Medicine
Presby University Hospital
University Pittsburgh
University Pa
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
University of Pennsylvania Health System -
University of Pittsburgh Medical Center -
McGill University Faculty of Medicine -
Harvard University
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1447292982 | |
| NPPES Provider LastName | LUGER | |
| NPPES Provider FirstName | SELINA | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 444.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447292982 |
| Last Name Of The Provider | LUGER |
| First Name Of The Provider | SELINA |
| View All |
Similar Doctors
|
Dr. Frederick S. Brunk, MD |
|
Dr. Mary Ellen Martin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James E. Thompson, MD |
|
|
Dr. David J. Vaughn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick G. Dold, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rebecca J. Jaslow, MD |
|
|
Dr. Lainie Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth P. Henske, MD |
|
|
Dr. Hossein Borghaei, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael E. Klein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel M. Geynisman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edith P. Mitchell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam Bagg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lee P. Schacter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fengwei Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noelle V. Frey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick M. Fellin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Porter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Namrata Vijayvergia, MD
This Doctor is OpenDoctor Recommended.
|